User login
Highlights of Clinical Symposia
A supplement to Skin & Allergy News International
The articles in this supplement are based on presentations made at satellite symposia held July 3, 2010, in Paris, France, and July 3, 2010, in Athens, Greece.
•Contents
•Faculty/Faculty Disclosure
To view the supplement, click the image above.
Contents
Long-Term Benefit-Risk: Interpreting the Evidence
- Psoriasis as a Systemic Disease: Benefit-Risk Considerations
- Long-Term Efficacy: What Do We Really Know?
- Six Years of Infusion Therapy: What Have We Learned?
New Views on Nail Psoriasis and Treatment
- The Magnitude and Impact of Nail Psoriasis
- Understanding the Link Between Psoriasis and Arthritis
- Current Management of Psoriasis With Nail Involvement
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
Chair, Psoriasis Research Unit, Baylor Research Institute
Clinical Professor, University of Texas
Southwestern Medical School
Dallas, Texas, USA
Dr Menter is on the advisory board for Abbott Laboratories, Amgen Inc., Astellas Pharma Inc., Centocor Ortho-Biotech Inc., Galderma S.A., Genentech Inc., Warner Chilcott, and Wyeth (Pfizer); is a consultant for Abbott, Amgen, Astellas, Centocor, Eli Lilly and Company, Galderma, Genentech, Stiefel Laboratories, Inc., Warner Chilcott, and Wyeth; is an investigator for Abbott, Allergan Inc., Amgen, Astellas, Asubio Pharma Co., Ltd., Celgene Corporation, Centocor, DUSA Pharmaceuticals, Inc., Eli Lilly, Genentech, Novartis AG, Novo Nordisk Inc., Pfizer, Promius Pharma, LLC, Stiefel, Syntrix Biosystems, Warner Chilcott, and Wyeth; is a speaker for Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Warner Chilcott, and Wyeth; has received grant funds from Abbott, Allergan, Amgen, Astellas, Asubio, Celgene, Centocor, DUSA, Eli Lilly, Genentech, Novartis, Novo Nordisk, Pfizer, Promius, Stiefel, and Syntrix Biosystems; and has received honoraria from Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Stiefel, Warner Chilcott, and Wyeth.
Kristian Reich, MD
Professor of Dermatology
Georg-August-University Gottingen
Partner, Dermatologikum Hamburg
Hamburg, Germany
Dr Reich has received clinical grants from and is a consultant for Abbott, Biogen-Idec, Centocor, Essex, Pfizer, Schering, and Wyeth (Pfizer).
Sergio Chimenti, MD
Chairman and Professor
Department of Dermatology
University of Rome Tor Vergata
Policlinico Tor Vergata
Rome, Italy
Dr Chimenti is a speaker for Schering-Plough Corporation
Robert Baran, MD
Honorary Professor of the University of Franche-Comté
Nail Disease Centre
Cannes, France
Dr Baran has nothing to disclose.
Denis McGonagle, PhD, MB, FRCPI
Professor of Investigative Rheumatology
Academic Unit of Musculoskeletal Disease
University of Leeds
Leeds, United Kingdom
Dr McGonagle has nothing to disclose.
Dimitris Rigopoulos, MD
Assistant Professor of Dermatology
Department of Dermatology, Andreas Syggros Hospital
Athens, Greece
Dr Rigopoulos has nothing to disclose.
A supplement to Skin & Allergy News International
The articles in this supplement are based on presentations made at satellite symposia held July 3, 2010, in Paris, France, and July 3, 2010, in Athens, Greece.
•Contents
•Faculty/Faculty Disclosure
To view the supplement, click the image above.
Contents
Long-Term Benefit-Risk: Interpreting the Evidence
- Psoriasis as a Systemic Disease: Benefit-Risk Considerations
- Long-Term Efficacy: What Do We Really Know?
- Six Years of Infusion Therapy: What Have We Learned?
New Views on Nail Psoriasis and Treatment
- The Magnitude and Impact of Nail Psoriasis
- Understanding the Link Between Psoriasis and Arthritis
- Current Management of Psoriasis With Nail Involvement
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
Chair, Psoriasis Research Unit, Baylor Research Institute
Clinical Professor, University of Texas
Southwestern Medical School
Dallas, Texas, USA
Dr Menter is on the advisory board for Abbott Laboratories, Amgen Inc., Astellas Pharma Inc., Centocor Ortho-Biotech Inc., Galderma S.A., Genentech Inc., Warner Chilcott, and Wyeth (Pfizer); is a consultant for Abbott, Amgen, Astellas, Centocor, Eli Lilly and Company, Galderma, Genentech, Stiefel Laboratories, Inc., Warner Chilcott, and Wyeth; is an investigator for Abbott, Allergan Inc., Amgen, Astellas, Asubio Pharma Co., Ltd., Celgene Corporation, Centocor, DUSA Pharmaceuticals, Inc., Eli Lilly, Genentech, Novartis AG, Novo Nordisk Inc., Pfizer, Promius Pharma, LLC, Stiefel, Syntrix Biosystems, Warner Chilcott, and Wyeth; is a speaker for Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Warner Chilcott, and Wyeth; has received grant funds from Abbott, Allergan, Amgen, Astellas, Asubio, Celgene, Centocor, DUSA, Eli Lilly, Genentech, Novartis, Novo Nordisk, Pfizer, Promius, Stiefel, and Syntrix Biosystems; and has received honoraria from Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Stiefel, Warner Chilcott, and Wyeth.
Kristian Reich, MD
Professor of Dermatology
Georg-August-University Gottingen
Partner, Dermatologikum Hamburg
Hamburg, Germany
Dr Reich has received clinical grants from and is a consultant for Abbott, Biogen-Idec, Centocor, Essex, Pfizer, Schering, and Wyeth (Pfizer).
Sergio Chimenti, MD
Chairman and Professor
Department of Dermatology
University of Rome Tor Vergata
Policlinico Tor Vergata
Rome, Italy
Dr Chimenti is a speaker for Schering-Plough Corporation
Robert Baran, MD
Honorary Professor of the University of Franche-Comté
Nail Disease Centre
Cannes, France
Dr Baran has nothing to disclose.
Denis McGonagle, PhD, MB, FRCPI
Professor of Investigative Rheumatology
Academic Unit of Musculoskeletal Disease
University of Leeds
Leeds, United Kingdom
Dr McGonagle has nothing to disclose.
Dimitris Rigopoulos, MD
Assistant Professor of Dermatology
Department of Dermatology, Andreas Syggros Hospital
Athens, Greece
Dr Rigopoulos has nothing to disclose.
A supplement to Skin & Allergy News International
The articles in this supplement are based on presentations made at satellite symposia held July 3, 2010, in Paris, France, and July 3, 2010, in Athens, Greece.
•Contents
•Faculty/Faculty Disclosure
To view the supplement, click the image above.
Contents
Long-Term Benefit-Risk: Interpreting the Evidence
- Psoriasis as a Systemic Disease: Benefit-Risk Considerations
- Long-Term Efficacy: What Do We Really Know?
- Six Years of Infusion Therapy: What Have We Learned?
New Views on Nail Psoriasis and Treatment
- The Magnitude and Impact of Nail Psoriasis
- Understanding the Link Between Psoriasis and Arthritis
- Current Management of Psoriasis With Nail Involvement
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
Chair, Psoriasis Research Unit, Baylor Research Institute
Clinical Professor, University of Texas
Southwestern Medical School
Dallas, Texas, USA
Dr Menter is on the advisory board for Abbott Laboratories, Amgen Inc., Astellas Pharma Inc., Centocor Ortho-Biotech Inc., Galderma S.A., Genentech Inc., Warner Chilcott, and Wyeth (Pfizer); is a consultant for Abbott, Amgen, Astellas, Centocor, Eli Lilly and Company, Galderma, Genentech, Stiefel Laboratories, Inc., Warner Chilcott, and Wyeth; is an investigator for Abbott, Allergan Inc., Amgen, Astellas, Asubio Pharma Co., Ltd., Celgene Corporation, Centocor, DUSA Pharmaceuticals, Inc., Eli Lilly, Genentech, Novartis AG, Novo Nordisk Inc., Pfizer, Promius Pharma, LLC, Stiefel, Syntrix Biosystems, Warner Chilcott, and Wyeth; is a speaker for Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Warner Chilcott, and Wyeth; has received grant funds from Abbott, Allergan, Amgen, Astellas, Asubio, Celgene, Centocor, DUSA, Eli Lilly, Genentech, Novartis, Novo Nordisk, Pfizer, Promius, Stiefel, and Syntrix Biosystems; and has received honoraria from Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Stiefel, Warner Chilcott, and Wyeth.
Kristian Reich, MD
Professor of Dermatology
Georg-August-University Gottingen
Partner, Dermatologikum Hamburg
Hamburg, Germany
Dr Reich has received clinical grants from and is a consultant for Abbott, Biogen-Idec, Centocor, Essex, Pfizer, Schering, and Wyeth (Pfizer).
Sergio Chimenti, MD
Chairman and Professor
Department of Dermatology
University of Rome Tor Vergata
Policlinico Tor Vergata
Rome, Italy
Dr Chimenti is a speaker for Schering-Plough Corporation
Robert Baran, MD
Honorary Professor of the University of Franche-Comté
Nail Disease Centre
Cannes, France
Dr Baran has nothing to disclose.
Denis McGonagle, PhD, MB, FRCPI
Professor of Investigative Rheumatology
Academic Unit of Musculoskeletal Disease
University of Leeds
Leeds, United Kingdom
Dr McGonagle has nothing to disclose.
Dimitris Rigopoulos, MD
Assistant Professor of Dermatology
Department of Dermatology, Andreas Syggros Hospital
Athens, Greece
Dr Rigopoulos has nothing to disclose.
Highlights of Clinical Symposia
Highlights of Clinical Symposia
